Ascendia

  MARKET NEWS

Valneva & Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidate
Caribou Biosciences Announces Fast Track Designations to CB-010 in Refractory SLE & to CB-012 in Relapsed or Refractory AML
Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy
Sapio Sciences Advances The World's First AI-Powered Lab Assistant
Longeveron Announces Positive Type C Meeting With FDA Regarding Pathway to BLA
Denali Therapeutics Announces Successful Meeting With FDA
West Completes $80-Million Manufacturing Expansion to Support Diabetes & Obesity Treatments for Patients Worldwide
Nuvectis Pharma Announces Orphan Drug Designation for the Treatment of ARID1a-Deficient Ovarian, Fallopian Tube & Primary Peritoneal Cancers
Purdue Researchers Take Inspiration From Viruses to Improve Delivery of Nucleic Acid-Based Therapies to Cancer Cells
ENA Respiratory Progresses Phase 1b Study of its Dry Powder Formulation of Intranasal Innate Immunomodulator

  EXPERT CONTENT & RESOURCES

Who is AbbVie Contract Manufacturing?

Who is AbbVie Contract Manufacturing?

As an embedded CMO, we leverage decades of scientific expertise, operational excellence, and best-in-class facilities to provide you with….

Presentation: Strategies for Amorphous Solid Dispersion Product Development

Presentation: Strategies for Amorphous Solid Dispersion Product Development

In this presentation, Dr. Schlesinger demonstrates how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design…..

Meet Gaelic Laboratories, Your Trusted Testing & Manufacturing Partner

Meet Gaelic Laboratories, Your Trusted Testing & Manufacturing Partner

Gaelic Laboratories today announces its new website, which contains details about this world-class Beta-Lactam (penicillin) manufacturer’s….

  FEATURED EDITORIAL

  COMPANY PROFILE

Triclinic Labs has earned a reputation as the industry’s choice for comprehensive solid-state materials analysis and solid-form development. Our scientists have more than four decades of expertise in pharmaceutical and specialty chemical development. We offer contract research services broadly described as physical and analytical chemistry. Click here for more.

  WHITEPAPERS & WEBINARS

Click image to watch video

WEBINAR - Development of Orally Delivered GLP-1 Therapeutics…From Diabetes to Obesity and Beyond

WEBINAR - Development of Orally Delivered GLP-1 Therapeutics…From Diabetes to Obesity and Beyond

Join Quotient Sciences’ experts on July 18 as we explore the latest developments in orally-delivered GLP-1 agonists, the potential for these therapeutics and overcoming the manufacturing challenges.

WEBINAR - Enabling Upstream Intensified Bioprocessing

WEBINAR - Enabling Upstream Intensified Bioprocessing

Intensified upstream bioprocesses are being developed to increase productivity while reducing footprint, costs, and timelines for manufacturing. The higher cell densities generated by….

  WHITEPAPERS & WEBINARS

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

It is widely reported that 40% of New Chemical Entities (NCEs) in the pharmaceutical industry are poorly soluble, leading to inadequate bioavailablity. Spray drying is one of the most promising particle engineering technologies used to overcome solubility issues in active …

WHITEPAPER - Versatility of Geleol™ Mono- and Diglycerides NF

WHITEPAPER - Versatility of Geleol™ Mono- and Diglycerides NF

By: Jasmine Musakhanian, Senior Scientific Director, Gattefossé

INTRODUCTION

Mono and diglycerides, also known as partial glycerides, are versatile lipid excipients that play a pivotal role in the realization of drug products and nutraceuticals. Some well-known excipients in this category are …

WHITEPAPER - Efficient Development of Miniature Drug-Loaded Implants

WHITEPAPER - Efficient Development of Miniature Drug-Loaded Implants

Drug-eluting implants offer a unique approach to overcoming challenges associated with traditional drug delivery methods. They can provide sustained, continuous release of a therapeutic at the desired site of action.

Download our latest white paper, jointly authored with MeltPrep, to …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

September 11 – Bioavailability
September 18 – Capsules